These reasons are also why we are upgrading ARM to a Buy, with numerous caveats for an improved margin of safety. Read more ...

Astellas Pharma’s strong pipeline and revenue growth support a positive outlook. See why ALPMF stock is a "Buy," driven by ...

Treasury collateral is rising as the Fed halts QT, but the debt ceiling resolution could trigger a bond yield rally. February ...